SFN and classic Hodgkin lymphoma: In conclusion, we have shown that SFN is a suppressor of tumor growth and survival as well as a strong immunomodulatory agent that induces NK cell-associated anti-tumor immune responses in cHL, in part through STING-dependent mechanisms (Fig. 1G).